Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 12, 2000, Pages 3963-3971

  Renno, R Z ^a   Delori, F C ^a   Holzer, R A ^a   Gragoudas, E S ^a   Miller, J W ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CASPASE 3; LUTETIUM; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CAPILLARY; RETINA MACULA AGE RELATED DEGENERATION;

ANGIOSTATINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CAPILLARIES; CASPASE 3; CASPASES; CATTLE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; COUMARINS; DRUG COMBINATIONS; DRUG SYNERGISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; METALLOPORPHYRINS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PIGMENT EPITHELIUM OF EYE; PLASMINOGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINAL VESSELS;

EID: 0033753701     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. The Framingham Eye Study Monograph. An ophthalmological epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975
2. Cataracts and macular degeneration in older Americans
3. Senile macular degeneration: A case controlled study
4. Subfoveal choroidal neovascular membranes in age related macular degeneration: Visual prognosis in eyes with relatively good initial visual acuity
5. Age related macular degeneration
6. Photodynamic therapy for choroidal neovascularization due to age-related macular degeneration with verteporfin: Results of a single treatment in a phase I and II study
7. Photodynamic therapy for choroidal neovascularization due to age-related macular degeneration with verteporfin: Results of retreatments in a phase I and II study
8. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, Report 1. Verteporfin (Visudyne TM) therapy of subfoveal choroidal neovascularization in age-related macular degeneration: One year results of two randomized clinical trials
9. Photodynamic therapy
10. The photobiology of photodynamic therapy: Cellular targets and mechanisms
11. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor
12. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization
13. Photodynamic therapy of exudative age-related macular degeneration
14. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin
15. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: Selective treatment of choroidal neovascularization in monkeys
16. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
17. Angiostatin induces and sustains dormancy of human primary tumors in mice
18. Combined effects of angiostatin and ionizing radiation in antitumour therapy
19. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
20. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells
21. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis
22. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines
23. Photodynamic therapy induces caspase-3 activation in HL-60 cells
24. Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces tyrosine phosphorylation events and DNA fragmentation in murine P815 cells
25. Lutetium Texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizer
26. Localization and efficacy analysis of the phototherapeutic Lutetium Texaphyrin (PCI-0123) in the murine EMT6 sarcoma model
27. Intracellular events associated with uptake of a monomeric photosensitizer, benzoporphyrin derivative monoacid ring A (BPD) and its subsequent activation with light
28. Association of ceramide accumulation with photodynamic treatment-induced cell death
29. Photodynamic therapy induced apoptosis in lymphoma cells: Translocation of cytochrome c causes inhibition of respiration as well as caspase activation
30. Photodynamic therapy: A mitochondrial inducer of apoptosis
31. Apoptosis or necrosis following photofrin photosensitization: Influence of the incubation protocol
32. Apoptosis: A basic biological phenomenon with wide ranging implications
33. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
34. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
35. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
36. Bcl-2 overexpression in the HaCaT cell line is associated with a different membrane fatty acid composition and sensitivity to oxidative stress
37. The proto-oncogene Bcl-2 and its role in regulating apoptosis
38. Differential requirement for caspase 9 in apoptotic pathways in vivo
39. Multiple forms of angiostatin induce apoptosis in endothelial cells
40. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge
41. Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers
42. Biodistribution of photosensitizing agents
43. Photodynamic therapy
44. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in Hela cells treated with photodynamic therapy
45. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to seven weeks after treatment
46. The Induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
47. Overexpression of Bcl-X prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA
48. Antisense Bcl-2 retrovirus vector increases the sensitivity of a human gastric carcinoma cell line to photodynamic therapy
49. Angiostatin binds ATP synthase on the surface of human endothelial cells